A Louisiana senator is calling for a closed drug formulary for the state’s Worker’s Compensation program, to help combat the overutilization of opioids and compounded drugs.
A Louisiana senator is calling for a closed drug formulary for the state’s worker’s compensation program, to help combat the overutilization of opioids and compounded drugs.
Related: HIV/AIDs drugs reclassified at Aetna, Coventry in Florida
Sen. Danny Martiny (Rep.) filed S.B. 256, which says the state should switch to a closed formulary. The bill also says the Office of Worker’s Compensation should set up a Closed Formulary Oversight Panel made up of pharmacists and physicians.
Closed formularies, which have reduced workers comp medical costs in Ohio, Texas and Washington, require proof that non-formulary medications - or “N” drugs - are medically necessary before they can be prescribed to injured workers, according to an article in Business Insurance. A limited list of covered medications - or “Y” drugs - don’t require preauthorization.
According to the bill, "N" drugs would include medications labeled narcotics by FDA, any compounded drugs or compound medication, any experimental drugs and any drugs that aren’t listed on the closed formulary at the time of prescription.
The closed formulary won’t apply to claims with a date of injury prior to Jan. 1, 2016, according to S.B. 256.
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More